糖尿病对肥厚型心肌病临床表型的影响
本研究纳入西班牙和以色列两个三级医疗中心的937例年龄≥40岁的肥厚型心肌病患者,其中102例(8.7%)合并糖尿病。倾向性评分匹配294例队列分析显示,合并糖尿病的肥厚型心肌病患者诊断年龄更大、合并症更多、舒张功能障碍和肺动脉高压及显著二尖瓣反流更常见,NYHA心功能分级更高且运动能力更低,15年死亡率显著更高。
要点
- 合并糖尿病的肥厚型心肌病患者心力衰竭症状更重、运动能力更低,主要与舒张功能障碍相关。
- 糖尿病是肥厚型心肌病患者15年死亡率增高的独立相关因素(22% vs 15%)。
- 合并糖尿病的肥厚型心肌病患者起搏器植入率更高,但猝死和ICD适当治疗无差异。
核心结论
- 合并糖尿病的肥厚型心肌病患者年龄更大、心血管风险谱更差,功能容量更低且心力衰竭症状更多,主要归因于舒张功能障碍。
- 合并糖尿病的肥厚型心肌病患者15年死亡率显著高于无糖尿病患者(22% vs 15%,P=0.03),但猝死、ICD适当治疗和心脏移植无差异。
研究设计与样本
- 回顾性队列研究,纳入西班牙和以色列两个三级医疗中心937例年龄≥40岁诊断为肥厚型心肌病的患者。
- 另分析倾向性评分匹配的294例患者队列。
- 合并糖尿病患者102例(8.7%)。
主要发现
- 合并糖尿病患者诊断时年龄中位数56岁(IQR 47-67)vs 53岁(IQR 43-63),P=0.02。
- 合并糖尿病患者舒张功能障碍、肺动脉高压、显著二尖瓣反流和起搏器植入的患病率更高。
- 合并糖尿病患者NYHA心功能分级更高(P<0.001),运动能力更低[7.0 METS(IQR 5.0-10.0)vs 9.0 METS(IQR 6.6-11.0),P=0.002]。
- 上述发现在调整年龄、性别、来源国家、高血压和冠心病后仍独立存在。
- 合并糖尿病患者15年死亡率显著更高(22% vs 15%,P=0.03),猝死、ICD适当治疗和心脏移植无差异。
临床怎么用
- 对合并糖尿病的肥厚型心肌病患者应更积极评估心力衰竭症状和舒张功能。
- 合并糖尿病的肥厚型心肌病患者运动能力和预后更差,需加强心血管风险因素管理。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS: Diabetes mellitus (DM) aggravates the clinical features of ischaemic and hypertensive heart diseases and worsens the prognosis of heart failure patients. Hypertrophic cardiomyopathy (HCM) and diabetes coexist fairly frequently in elderly patients but the impact of DM on the clinical phenotype of HCM is yet unknown. We sought to describe if predominant features of heart failure in DM patients exist independently in HCM. METHODS AND RESULTS: We reviewed clinical characteristics of 937 patients, age ≥40, diagnosed with HCM, from two tertiary medical centres in Spain and Israel. A propensity score matched cohort of 294 patients was also analysed. Our cohort comprised 102 HCM patients with diabetes (8.7%). Patients with DM were older at diagnosis {median 56 [interquartile range (IQR) 47-67] vs. 53 (IQR 43-63), P = 0.02} and had a higher prevalence of comorbidities. Hypertrophic cardiomyopathy patients with DM had a higher prevalence of diastolic dysfunction, pulmonary hypertension, significant mitral regurgitation, and pacemaker implantation. Hypertrophic cardiomyopathy patients with DM had a higher New York Heart Association (NYHA) class (P < 0.001) and lower exercise capacity [7.0 METS (IQR 5.0-10.0) vs. 9.0 METS (IQR 6.6-11.0), P = 0.002]. These findings were independent of age, gender, country of origin, hypertension, and coronary artery disease. Patients with diabetes had a significantly higher 15-year mortality (22% vs. 15%, P = 0.03), with no differences in sudden cardiac death, appropriate implanted cardioverter-defibrillator therapy, or heart transplantation. CONCLUSION: Hypertrophic cardiomyopathy patients with diabetes are older and have a higher cardiovascular risk profile. They have a lower functional capacity and more heart failure symptoms due to diastolic dysfunction.
引用
- Wasserstrum Y, Barriales-Villa R, Fernández-Fernández X, et al. The impact of diabetes mellitus on the clinical phenotype of hypertrophic cardiomyopathy. Eur Heart J. 2019. PMID: 30358878. doi:10.1093/eurheartj/ehy625
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。